MediciNova, Inc.
DE ˙ DB ˙ US58468P2065
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT
1.859,00 € ↑5,00 (0,27%)
2021-12-19
DEL PRIS
SecurityDE:RMN / MediciNova, Inc.
InstitutionGoldman Sachs Group Inc
Latest Disclosed Ownership27,824 shares
Latest Disclosed Value $ 38,118
Goldman Sachs Group Inc reports 5.08% increase in ownership of RMN / MediciNova, Inc.

On May 15, 2026 - Goldman Sachs Group Inc filed a 13F-HR form disclosing ownership of 27,824 shares of MediciNova, Inc. (DE:RMN) valued at $38,118 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 26,480 shares of MediciNova, Inc.. This represents a change in shares of 5.08% during the quarter. The current value of the position is $51,724,816 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MEDICINOVA CMN 58468P206 27,824 1,344 5.08 38 11.76 0.0000
2026-02-10 2025-12-31 13F MEDICINOVA CMN 58468P206 26,480 26,480 35 0.0000
2025-02-11 2024-12-31 13F MEDICINOVA CMN 58468P206 0 -10,246 -100.00 0 -100.00
2024-11-14 2024-09-30 13F MEDICINOVA CMN 58468P206 10,246 10,246 22 0.0000
2024-05-15 2024-03-31 13F MEDICINOVA CMN 58468P206 0 -10,944 -100.00 0 -100.00
2024-05-14 2023-12-31 13F/A-2 MEDICINOVA CMN 58468P206 10,944 10,944 16 0.0000
2024-03-01 2023-12-31 13F/A-1 MEDICINOVA CMN 58468P206 10,944 10,944 16 0.0000
2024-02-13 2023-12-31 13F MEDICINOVA CMN 58468P206 10,944 10,944 16 0.0000
2024-05-14 2023-06-30 13F/A-1 MEDICINOVA CMN 58468P206 0 -22,702 -100.00 0 -100.00
2023-08-15 2023-06-30 13F MEDICINOVA CMN 58468P206 0 -22,702 0
2024-05-14 2023-03-31 13F/A-1 MEDICINOVA CMN 58468P206 22,702 -28,317 -55.50 49 -52.88 0.0000
2023-05-11 2023-03-31 13F MEDICINOVA CMN 58468P206 22,702 -28,317 49 0.0000
2024-05-14 2022-12-31 13F/A-1 MEDICINOVA CMN 58468P206 51,019 51,019 105 0.0000
2023-02-13 2022-12-31 13F MEDICINOVA CMN 58468P206 51,019 51,019 105 0.0000
2022-05-16 2022-03-31 13F MEDICINOVA CMN 58468P206 0 -33,516 -100.00 0 -100.00
2022-02-17 2021-12-31 13F/A-1 MEDICINOVA CMN 58468P206 33,516 -869 -2.53 90 -30.77 0.0000
2022-02-14 2021-12-31 13F MEDICINOVA CMN 58468P206 33,516 -869 90 0.0000
2022-01-20 2021-09-30 13F/A-1 MEDICINOVA CMN 58468P206 34,385 -48,439 -58.48 130 -63.07 0.0000
2021-11-10 2021-09-30 13F MEDICINOVA CMN 58468P206 34,385 -48,439 130 0.0000
2021-08-13 2021-06-30 13F MEDICINOVA CMN 58468P206 82,824 19,118 30.01 352 9.66 0.0001
2021-05-17 2021-03-31 13F MEDICINOVA CMN 58468P206 63,706 4,489 7.58 321 3.22 0.0001
2021-02-12 2020-12-31 13F MEDICINOVA CMN 58468P206 59,217 45,302 325.56 311 326.03 0.0001
2020-11-13 2020-09-30 13F MEDICINOVA CMN 58468P206 13,915 -14,651 -51.29 73 -52.90 0.0000
2020-08-12 2020-06-30 13F MEDICINOVA CMN 58468P206 28,566 -1,915 -6.28 155 37.17 0.0000
2020-05-15 2020-03-31 13F MEDICINOVA CMN 58468P206 30,481 -24,909 -44.97 113 -69.71 0.0000
2020-02-14 2019-12-31 13F MEDICINOVA CMN 58468P206 55,390 16,160 41.19 373 19.55 0.0001
2019-11-14 2019-09-30 13F MEDICINOVA CMN 58468P206 39,230 -3,487 -8.16 312 -24.09 0.0001
2019-08-14 2019-06-30 13F MEDICINOVA CMN 58468P206 42,717 -6,111 -12.52 411 1.73 0.0001
2019-05-15 2019-03-31 13F MEDICINOVA CMN 58468P206 48,828 -46,495 -48.78 404 -48.14 0.0001
2019-02-14 2018-12-31 13F MEDICINOVA CMN 58468P206 95,323 95,323 779 0.0002
2018-11-14 2018-09-30 13F MEDICINOVA CMN 58468P206 0 -12,706 -100.00 0 -100.00
2018-08-14 2018-06-30 13F MEDICINOVA CMN 58468P206 12,706 12,706 101 0.0000
2018-02-14 2017-12-31 13F MEDICINOVA CMN 58468P206 0 -25,863 -100.00 0 -100.00
2017-11-14 2017-09-30 13F MEDICINOVA CMN 58468P206 25,863 -21,793 -45.73 165 -34.26 0.0000
2017-08-14 2017-06-30 13F MEDICINOVA CMN 58468P206 47,656 20,567 75.92 251 54.94 0.0001
2017-05-18 2017-03-31 13F/A-1 MEDICINOVA CMN 58468P206 27,089 -760 -2.73 162 -3.57 0.0000
2017-05-15 2017-03-31 13F MEDICINOVA CMN 58468P206 27,089 162
2017-02-14 2016-12-31 13F MEDICINOVA CMN 58468P206 27,849 27,849 0.00 168 0.0000
2016-08-15 2016-06-30 13F MEDICINOVA CMN 58468P206 0 -35,000 -100.00 0 -100.00
2016-05-13 2016-03-31 13F MEDICINOVA CMN 58468P206 35,000 35,000 257 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.